INCREASED DENSITY OF THE THALAMUS ON CT SCANS IN PATIENTS WITH GM2-GANGLIOSIDOSES

被引:0
|
作者
BRISMAR, J
BRISMAR, G
COATES, R
GASCON, G
OZAND, P
机构
[1] KING FAISAL SPECIALIST HOSP & RES CTR,DEPT SURG,OPHTHALMOL SECT,RIYADH 11211,SAUDI ARABIA
[2] KING FAISAL SPECIALIST HOSP & RES CTR,DEPT PEDIAT,RIYADH 11211,SAUDI ARABIA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:125 / 130
页数:6
相关论文
共 50 条
  • [21] EPSTEIN-BARR VIRUS-TRANSFORMED LYMPHOID-CELL LINES AS A NEW MODEL SYSTEM IN CULTURE FOR THE STUDY OF GM2-GANGLIOSIDOSES - TAY-SACHS AND SANDHOFF DISEASES
    MARET, A
    SALVAYRE, R
    NEGRE, A
    BES, JC
    DOUSTEBLAZY, L
    BIOLOGY OF THE CELL, 1985, 53 (03) : 293 - 296
  • [22] GM2 Gangliosidoses patient journey: Results from interviews with Late-Onset GM2 patients and frontline treaters
    Lopshire, M.
    Flores, A.
    Burns, J.
    Gould, R.
    Batsu, I.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S74 - S74
  • [23] Motor function limitations and impacts among patients with GM1 AND GM2 gangliosidoses in the United States: A qualitative study
    Ng-Mak, Daisy
    Rodriguez, Maria Belen
    Heuer, Karli
    Waggoner, Christine
    Jussila, Diana
    Pulikottil-Jacob, Ruth
    Perez, Nancy Gabriela
    Krupnick, Robert
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (04)
  • [24] GM2 gangliosidoses: evaluation of clinical, biochemical and genetic findings of patients with three novel mutations
    Gurbuz, Berrak Bilginer
    Bulut, Fatma Derya
    Ucar, Habibe Koc
    Sarigecili, Esra
    Sarikepe, Bilge
    Yuregir, Ozge Ozalp
    CUKUROVA MEDICAL JOURNAL, 2021, 46 (03): : 1201 - 1207
  • [25] Humanistic burden of neurodegenerative lysosomal disorders in the US: insights from caregivers of patients living with GM1 and GM2 gangliosidoses
    Rodriguez, M.
    Heuer, K.
    Waggoner, C.
    Jussila, D.
    Perez, N.
    Krupnick, R.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S186 - S186
  • [26] A natural history study of late-infantile and juvenile GM1 and GM2 gangliosidoses (PRONTO): Patients' and caregivers' assessments
    Giugliani, Roberto
    Harmatz, Paul
    Heron, Benedicte
    Patterson, Marc
    Schneider, Susanne
    Bourchany, Aurelie
    Hahn, Andreas
    Valle, Daniel A. D.
    Barone, Rita Maria Elisa
    Chabrol, Brigitte
    Ardissone, Anna
    Batzios, Spyros
    Scarpa, Maurizio
    Carp, Nicoleta
    Crapard, Laetitia
    de Frutos, Laura Lopez
    Quintela, Renata Medinaceli
    Thiers, Aurelien
    Luzy, Cecile Paquet
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [27] The AMETHIST phase 3 trial of venglustat in patients with GM2 gangliosidoses and related diseases: baseline characteristics
    Zheng, R.
    Tifft, C.
    Minini, P.
    Batsu, I.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S186 - S186
  • [28] A natural history study of pediatric patients with early onset of GM1 gangliosidosis, GM2 gangliosidoses, or gaucher disease type 2 (RETRIEVE)
    Heron, Benedicte
    Batzios, Spyros
    Mengel, Eugen
    Giugliani, Roberto
    Patterson, Marc
    Gautschi, Matthias
    Cornelisse, Peter
    Trokan, Luba
    Schwierin, Barbara
    Rohrbach, Marianne
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [29] Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients
    Welford, Richard W. D.
    Farine, Herve
    Steiner, Michel
    Garzotti, Marco
    Dobrenis, Kostantin
    Sievers, Claudia
    Strasser, Daniel S.
    Amraoui, Yasmina
    Groenen, Peter M. A.
    Giugliani, Roberto
    Mengel, Eugen
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2022, 30
  • [30] GM2 gangliosidoses in Spain: Analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients
    Gort, Laura
    de Olano, Natalia
    Macias-Vidal, Judit
    Coll, Ma Josep
    GENE, 2012, 506 (01) : 25 - 30